Ftse Mib
34.433,90
-0,08%
DAX
18.693,46
0,06%
S&P 500
5.307,01
-0,27%
NASDAQ
16.801,54
-0,18%
Bitcoin
69.720,39
0,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Madrigal Pharmaceuticals Inc (MDGL) Madrigal Pharmaceuticals Inc (MDGL) Notizie

Madrigal Pharmaceuticals Inc

MDGL
235,06
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202422:36EDGAR2Form 8-K - Current report
07/5/202422:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/5/202422:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/5/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:06EDGAR2Form 8-K - Current report
07/5/202413:00GLOBEMadrigal Pharmaceuticals Reports First-Quarter 2024..
24/4/202422:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
23/4/202414:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
16/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
09/4/202414:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
03/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
19/3/202404:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
18/3/202421:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
15/3/202412:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
14/3/202421:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
06/3/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
05/3/202414:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
28/2/202413:10EDGAR2Form 8-K - Current report
28/2/202413:01EDGAR2Form 8-K - Current report
28/2/202413:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
28/2/202413:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
28/2/202412:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
14/2/202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
06/2/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
29/1/202414:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
26/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202419:45EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEMadrigal Pharmaceuticals Presents Five Health Economics..
03/1/202422:30GLOBEMadrigal Pharmaceuticals to Present at the 42nd Annual J.P...
22/12/202322:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
06/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 235,06

La tua Cronologia

NASDAQ
MDGL
Madrigal Pharmaceuticals
LSE
48BF
Res.mtg 16 A2aa
TSXV
BZI.H
USOTC
FOSUF
Fosun (PK)
EU
ACAQH
Credit Agricole SA 3.20%...
LBNK
STRUSDT
SourceLess
EU
CMHLB
Credit Mutuel Home Loan ...
BIT
P1JO70
BNP Paribas Issuance BV
BIT
S28970
Societe Generale Effekten
NASDAQ
AAYMKXX
Royal Bank of Canada Cap...
NASDAQI
WTREUPR
TSC Euro Water Security ...
BIT
P1VD85
NLBNPIT1VD85 20991231 3....
COIN
METCOUSD
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network